Form 4 for WGS GeneDx Holdings Corp.

Accepted 2022-04-06 00:00:00 ET · period of report 2022-04-04 · accession 0001209191-22-023517 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-04-06	2022-04-04	WGS	Ro Isaac	CFO	A - Grant	$0.00	+3,896	160.1K	+2%	$0
DM	2022-04-06	2022-04-04	WGS	Ro Isaac	CFO	A - Grant	$0.00	+323.8K	205.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-04-04	A	A	3,896	$0.00	160,085	D	—	—	(F1) The indicated shares were issued to the Reporting Person as a stock bonus. The stock bonus was fully-vested as of the date of issuance.
2	Derivative	Restricted Stock Unit	2022-04-04	A	A	118,350	$0.00	118,350	D	— · — to —	118,350 Class A Common Stock	(F3) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
3	Derivative	Employee Stock Option (Right to Buy)	2022-04-04	A	A	205,469	$0.00	205,469	D	$3.05 · — to 2032-04-03	205,469 Class A Common Stock	(F2) 6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.